Zevra Therapeutics Inc’s market performance has been stable in recent times. The company’s stock hit a 1-year high of $8.95 on 09/20/24 and a low of $3.89 for the same time frame on 11/13/23.
52-week price history of ZVRA Stock
Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Zevra Therapeutics Inc’s current trading price is -7.60% away from its 52-week high, while its distance from the 52-week low is 112.60%. The stock’s price range during the 52-week period has remained between $3.89 and $8.95. In the Healthcare sector, the company’s shares saw a trading volume of around 2.39 million for the day, which was evidently higher than the average daily volume of 0.95 million over the past three months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Market Capitalization and Financial Performance: An In-Depth Look
Zevra Therapeutics Inc (ZVRA) has experienced a quarterly rise of 83.78% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 435.17M and boasts a workforce of 69 employees.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 5.93, with a change in price of +3.69. Similarly, Zevra Therapeutics Inc recorded 695,185 in trading volume during the last 100 days, posting a change of +80.57%.
Examining ZVRA’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for ZVRA stands at 1.83. Similarly, the long-term debt-to-equity ratio is also 1.81.
ZVRA Stock Stochastic Average
Zevra Therapeutics Inc’s raw stochastic average for the past 50 days is presently 80.57%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 65.13%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 49.74% and 58.06%, respectively.
ZVRA Stock Price Performance Analysis
The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. The index has shown a price gain of 26.26% this year. Over the last six months, there has been a weaker performance of 43.58%. The price of ZVRA fallen by 15.18% during the last 30 days period. For the last 5-days stocks have improved 9.83%.
